"XBB" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonWhat COVID-19 variants are going around in April 2025? - Nebraska Medicine
What COVID-19 variants are going around in April 2025? Nebraska Medicine
(XBB) Stock Trading Blueprint (XBB:CA) - news.stocktradersdaily.com
(XBB) Stock Trading Blueprint (XBB:CA) news.stocktradersdaily.com
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design Duke University School of Medicine
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines Nature
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among a...
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...
Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...
Genomic Surveillance for SARS-CoV-2 Variants: ... Centers for Disease Control and Prevention | CDC (.gov)
COVID-19 Variant Update - IDSA
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to...
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System Nature
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-r...
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 Nature
Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice - Frontiers
Omicron XBB.1.5 subvariant causes severe pulmonary disease in K18-hACE-2 mice Frontiers
Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 su...
Neutralizing antibody responses to three XBB protein vaccines in older adults - Nature
Neutralizing antibody responses to three XBB protein vaccines in older adults Nature
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strai...
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity - Nature
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity Nature
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant Nature
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...
A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage...
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...
Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmis...
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids CIDRAP
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...
XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP
XBB booster offers protection against JN.1 infections, hospital cases, new data show CIDRAP
Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vacc...
Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan ScienceDirect.com
Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XB...
Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine
Durability of XBB.1.5 Vaccines against Omicron Subvariants The New England Journal of Medicine
Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...
Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vacci...
Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants - ASM J...
Molecular and structural insights into SARS-CoV-2 evolution: from BA.2 to XBB subvariants ASM Journals
A health advisory about the COVID-19 xbb variant has not been issued by the CDC - KGW
A health advisory about the COVID-19 xbb variant has not been issued by the CDC KGW
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthr...
Low neutralization of SARS-CoV-2 Omicron BA.5.2.48 and XBB.1 sub-variants in response to breakthrough infection by booster ScienceDirect.com
Comparing the COVID-19 Vaccines: How Are They Different? - Yale Medicine
Comparing the COVID-19 Vaccines: How Are They Different? Yale Medicine
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protectio...
Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booste...
Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booster Nature
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syr...
Immunogenicity and efficacy of XBB.1.5 rS vaccine against the EG.5.1 variant of SARS-CoV-2 in Syrian hamsters ASM Journals
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths - CIDRAP
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths CIDRAP
S. Korean health authorities reject baseless 'Omicron surge' warning - AFP Fact Check
S. Korean health authorities reject baseless 'Omicron surge' warning AFP Fact Check
Study Suggests Regular Vaccine Boosts May Help People Who Are Immunocompromised Fight COVID-19 - ...
Study Suggests Regular Vaccine Boosts May Help People Who Are Immunocompromised Fight COVID-19 Johns Hopkins Medicine
Early COVID‐19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Va...
Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination...
Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection Wiley Online Library
Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...
Fact Check: Old ‘Misleading’ Advisory Against XBB Variant Goes Viral On Whatsapp Amid Recent Surg...
Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB ...
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care work...
Risk factors and correlates of protection against XBB SARS-CoV-2 infection among health care workers ScienceDirect.com
A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16,...
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron s...
Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the abse...
Symptoms and Preventions of the COVID Omicron-XBB Variant - Siloam Hospitals
Symptoms and Preventions of the COVID Omicron-XBB Variant Siloam Hospitals
Study suggests COVID-19 infection no longer grants long-lasting immunity - Gavi, the Vaccine Alli...
Study suggests COVID-19 infection no longer grants long-lasting immunity Gavi, the Vaccine Alliance
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection - Scie...
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection ScienceDirect.com
Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England - The Lancet
Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England The Lancet
FAQ: Updated FDA Recommendations for COVID-19 Vaccines - IDSA
LB.1, or D-FLiRT, is the newest COVID subvariant. What do we know about it? Where has it come fro...
LB.1, or D-FLiRT, is the newest COVID subvariant. What do we know about it? Where has it come from? The Conversation
XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association
XBB.1.5 Omicron subvariant: Questions patients may have American Medical Association
Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against bro...
Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike -...
Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike ACS Publications
TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)
TAG-VE statement on Omicron sublineages BQ.1 and XBB World Health Organization (WHO)
Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England - The Lancet
Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England The Lancet
What you need to know about COVID FLiRT variants - Houston Public Media
What you need to know about COVID FLiRT variants Houston Public Media
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderl...
COVID Shots Could Use Another Update, Study Suggests - MedPage Today
COVID Shots Could Use Another Update, Study Suggests MedPage Today
Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico prote...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1 - C...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1 CIDRAP
New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration - A...
New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration Australian Broadcasting Corporation
Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story ci...
Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story circulating again Africa Check
Individuals carrying the HLA-B*15 allele exhibit favorable responses to COVID-19 vaccines but are...
Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-...
Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance BMC Infectious Diseases
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant Nature
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgen...
MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta - The Straits Times
MOH debunks claims that XBB Covid-19 variant more ‘toxic’ than Delta The Straits Times
Covid-19 vaccines still protect us: How do we get the best out of them? - Public Health Communica...
Covid-19 vaccines still protect us: How do we get the best out of them? Public Health Communication Centre
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - Centers for Disease Control and P...
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... Centers for Disease Control and Prevention | CDC (.gov)
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant PBS
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - The New England Jo...
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster The New England Journal of Medicine
Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network
Rising cases of COVID-19 variant, XBB.1.5 Mayo Clinic News Network
XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant - University of California - Dav...
XBB.1.5: What you need to know about COVID-19’s ‘Kraken’ variant University of California - Davis Health
Will COVID Vaccines Continue to Work Against JN.1 and Other New Variants? - IDSA
Will COVID Vaccines Continue to Work Against JN.1 and Other New Variants? IDSA
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variant...
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants ScienceDirect.com
The Updated COVID Vaccines Are Here: 9 Things to Know - Yale Medicine
The Updated COVID Vaccines Are Here: 9 Things to Know Yale Medicine
How much should people worry about Covid’s newly-dominant XBB.1.5 variant? Our medical analyst ex...
Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American
Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious Scientific American
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know Yale Medicine
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...
Covid variant 'Arcturus' is spreading: What to know about XBB.1.16 - NBC News
Covid variant 'Arcturus' is spreading: What to know about XBB.1.16 NBC News
Philippines 'need not worry' about omicron subvariant XBB.1.5 - DOH - ABS-CBN
Philippines 'need not worry' about omicron subvariant XBB.1.5 - DOH ABS-CBN
What You Need To Know About XBB.1.5, COVID’s Latest Variant - Texas A&M Today
What You Need To Know About XBB.1.5, COVID’s Latest Variant Texas A&M Today
Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)
Statement on the antigen composition of COVID-19 vaccines World Health Organization (WHO)
WHO issues initial Omicron XBB.1.16 risk assessment - CIDRAP
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID...
Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster ScienceDirect.com
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...
CORONAVIRUS Public urged to get XBB vaccine amid surge in COVID-19 cases - Focus Taiwan
CORONAVIRUS Public urged to get XBB vaccine amid surge in COVID-19 cases Focus Taiwan
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 The New England Journal of Medicine
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know American Society for Microbiology
Early Estimates of Bivalent mRNA Booster Dose Vaccine ... - Centers for Disease Control and Preve...
Early Estimates of Bivalent mRNA Booster Dose Vaccine ... Centers for Disease Control and Prevention | CDC (.gov)